Allmed Solutions Ltd

Tel Aviv Stock Exchange ALMD.TA

Allmed Solutions Ltd Shares (Diluted, Weighted) for the year ending December 31, 2023: 111,838

Allmed Solutions Ltd Shares (Diluted, Weighted) is 111,838 for the year ending December 31, 2023, a 27.31% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Allmed Solutions Ltd Shares (Diluted, Weighted) for the year ending December 31, 2022 was 87,848, a 12.93% change year over year.
Allmed Solutions Ltd Shares (Diluted, Weighted) for the year ending December 31, 2021 was 77,791, a -14.55% change year over year.
Allmed Solutions Ltd Shares (Diluted, Weighted) for the year ending December 31, 2020 was 91,041, a 28.08% change year over year.
Allmed Solutions Ltd Shares (Diluted, Weighted) for the year ending December 31, 2019 was 71,080, a -6.80% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Tel Aviv Stock Exchange: ALMD.TA

Allmed Solutions Ltd

CEO	Prof. Oz Shapira
IPO Date	Dec. 24, 2007
Location	Israel
Headquarters	2 Ha'Eshel Street
Employees	19
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.

Key trends

Past 5 years